Related Experiment Video
Updated: Jan 27, 2026

Rapid One-step Enzymatic Synthesis and All-aqueous Purification of Trehalose Analogues
Published on: February 17, 2017
Medical Treatment with Somatostatin Analogues in Acromegaly: Position Statement
Sang Ouk Chin1, Cheol Ryong Ku2, Byung Joon Kim3
1Department of Endocrinology and Metabolism, Kyung Hee University School of Medicine, Seoul, Korea.
Abstract:
The Korean Endocrine Society (KES) published clinical practice guidelines for the treatment of acromegaly in 2011. Since then, the number of acromegaly cases, publications on studies addressing medical treatment of acromegaly, and demands for improvements in insurance coverage have been dramatically increasing. In 2017, the KES Committee of Health Insurance decided to publish a position statement regarding the use of somatostatin analogues in acromegaly. Accordingly, consensus opinions for the position statement were collected after intensive review of the relevant literature and discussions among experts affiliated with the KES, and the Korean Neuroendocrine Study Group. This position statement includes the characteristics, indications, dose, interval (including extended dose interval in case of lanreotide autogel), switching and preoperative use of somatostatin analogues in medical treatment of acromegaly. The recommended approach is based on the expert opinions in case of insufficient clinical evidence, and where discrepancies among the expert opinions were found, the experts voted to determine the recommended approach.
More Related Videos
Related Concept Videos
Statements of the Second Law of Thermodynamics
Position-effect Variegation
Inhaled Medications
Position and Displacement
Serial Position Effect
Anatomical Positions
The body is upright, facing forward, and standing erect.
The feet are parallel and flat on the floor.
The arms are hanging by the...

